This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Albemarle Shares Rally 81% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
ALB has surged 81% in three months as forecast-topping earnings, Energy Storage volume growth and cost cuts offset pressure from weak lithium prices.
BASFY and ADAMA Partner to Advance Gilboa Fungicide in Europe
by Zacks Equity Research
BASF teams up with ADAMA to speed Gilboa fungicide rollout in Europe, offering a new mode of action as farmers face resistance and regulatory pressure.
Here's Why You Should Retain CF Industries Stock in Your Portfolio
by Zacks Equity Research
CF gains from strong global nitrogen demand and higher prices, supporting revenue and cash returns, even as rising natural gas costs pressure margins.
NEM to Sell Fuerte Shares Through Secondary Transaction Agreement
by Zacks Equity Research
Newmont plans to sell 6.77M Fuerte shares at C$4.35, raising about C$29.5M and cutting its stake to roughly 19.5% after the deal.
Celanese Extends Debt Maturities Through $1.4 Billion Refinancing
by Zacks Equity Research
CE completes a $1.4 billion refinancing to push out maturities, cuts near-term debt and modestly lifts its net borrowing rate.
Are You Looking for a Top Momentum Pick? Why Equinox Gold (EQX) is a Great Choice
by Zacks Equity Research
Does Equinox Gold (EQX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Has Buenaventura Mining (BVN) Outpaced Other Basic Materials Stocks This Year?
by Zacks Equity Research
Here is how Buenaventura (BVN) and Equinox Gold (EQX) have performed compared to their sector so far this year.
PRM Prices $550 Million Senior Secured Notes to Fund Acquisition
by Zacks Equity Research
PRM prices $550M of 6.250% senior secured notes due 2034, with proceeds and cash on hand set to fund the planned MMT acquisition.
BASF and OQEMA Ink Distribution Deal in Central and Eastern Europe
by Zacks Equity Research
BASFY partners with OQEMA to expand distribution of polymer dispersions and additives across Central and Eastern Europe starting Jan. 1, 2026.
BASFY to Divest Optical Brightening Agent Business to Catexel
by Zacks Equity Research
BASF SE agrees to sell its optical brightening agent business to Catexel, continuing its Winning Ways portfolio shift, with closing expected in Q1 2026.